109 related articles for article (PubMed ID: 9575313)
1. Various pathogenetic factors revolving around the central role of protein kinase C activation in the occurrence of cerebral vasospasm.
Asano T; Matsui T
Crit Rev Neurosurg; 1998 May; 8(3):176-87. PubMed ID: 9575313
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Connexin 40 Mediated by Nitric Oxide Attenuates Cerebral Vasospasm After Subarachnoid Hemorrhage via the Nitric Oxide-Cyclic Guanosine Monophosphate-Protein Kinase G Pathway.
Lan SH; Lai WT; Zheng SY; Yang L; Fang LC; Zhou L; Tang B; Duan J; Hong T
World Neurosurg; 2020 Apr; 136():e476-e486. PubMed ID: 31953101
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Asano T; Matsui T
Cell Mol Neurobiol; 1999 Feb; 19(1):31-44. PubMed ID: 10079963
[TBL] [Abstract][Full Text] [Related]
4. Interrelation between protein kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage.
Nishizawa S; Yamamoto S; Uemura K
Neurol Res; 1996 Feb; 18(1):89-95. PubMed ID: 8714544
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C and cerebral vasospasm.
Laher I; Zhang JH
J Cereb Blood Flow Metab; 2001 Aug; 21(8):887-906. PubMed ID: 11487724
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage.
Nishizawa S; Yamamoto S; Yokoyama T; Uemura K
Neurol Res; 1997 Oct; 19(5):558-62. PubMed ID: 9329037
[TBL] [Abstract][Full Text] [Related]
7. Obligatory roles of protein kinase C and nitric oxide in the regulation of cerebral vascular tone: an implication of a pathogenesis of vasospasm after subarachnoid haemorrhage.
Nishizawa S; Yokota N; Yokoyama T; Uemura K
Acta Neurochir (Wien); 1998; 140(10):1063-8. PubMed ID: 9856250
[TBL] [Abstract][Full Text] [Related]
8. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm.
Nishizawa S; Yamamoto S; Yokoyama T; Ryu H; Uemura K
Stroke; 1995 Oct; 26(10):1916-20; discussion 1920-1. PubMed ID: 7570748
[TBL] [Abstract][Full Text] [Related]
9. Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions.
Asano T
Crit Rev Neurosurg; 1999 Sep; 9(5):303-318. PubMed ID: 10525849
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C.
McNair LL; Salamanca DA; Khalil RA
Hypertension; 2004 Apr; 43(4):897-904. PubMed ID: 14981072
[TBL] [Abstract][Full Text] [Related]
11. Continuous elevation of intracellular Ca2+ is essential for the development of cerebral vasospasm.
Tani E; Matsumoto T
Curr Vasc Pharmacol; 2004 Jan; 2(1):13-21. PubMed ID: 15320829
[TBL] [Abstract][Full Text] [Related]
12. Relation between protein kinase C and calmodulin systems in cerebrovascular contraction: investigation of the pathogenesis of vasospasm after subarachnoid hemorrhage.
Nishizawa S; Peterson JW; Shimoyama I; Uemura K
Neurosurgery; 1992 Oct; 31(4):711-6. PubMed ID: 1407457
[TBL] [Abstract][Full Text] [Related]
13. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm.
Matsui T; Takuwa Y; Johshita H; Yamashita K; Asano T
J Cereb Blood Flow Metab; 1991 Jan; 11(1):143-9. PubMed ID: 1983998
[TBL] [Abstract][Full Text] [Related]
14. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
15. Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: from protein kinase C to protein tyrosine kinase.
Koide M; Nishizawa S; Ohta S; Yokoyama T; Namba H
Neurosurgery; 2002 Dec; 51(6):1468-74; discussion 1474-6. PubMed ID: 12445353
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction and vascular disease - a 30th anniversary update.
Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of vasoconstriction induced by endothelin-1 in smooth muscle of rabbit mesenteric artery.
Yoshida M; Suzuki A; Itoh T
J Physiol; 1994 Jun; 477(Pt 2):253-65. PubMed ID: 7932217
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm.
Nishizawa S; Chen D; Yokoyama T; Yokota N; Otha S
Acta Neurochir (Wien); 2000; 142(12):1409-15. PubMed ID: 11214636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
